Poorly Differentiated Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Poorly Differentiated Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial [Phase 1]
Phase 1 feasibility trial evaluating repurposed drugs for thyroid carcinoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer [NA]
A clinical trial update indicates recruitment for a study of Sacituzumab Govitecan in combination with immunotherapy for advanced thyroid ca…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer [Phase 2]
A Phase 2 clinical trial update for lenvatinib plus pembrolizumab in stage IVB unresectable or stage IVC metastatic anaplastic thyroid cance…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]
First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab with chemotherapy for anaplastic and poorly differentiated thyroid carcinoma; the study is active but …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC [Phase 2]
Phase 2 clinical trial evaluating MRG003 in combination with pucotenlimab for anaplastic thyroid carcinoma and poorly differentiated thyroid…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer [Phase 2]
Phase II trial of tunlametinib in NRAS-mutant advanced thyroid cancer is currently recruiting, evaluating differentiated, poorly differentia…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update indicating that XL092 for locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer …